ClinicalTrials.Veeva

Menu

Impact of Correction of Vitamin D Deficiency in Oxidative Stress in Patients With Prediabetes (VICOX)

I

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Status

Terminated

Conditions

Vitamin D Deficiency
Insulin Resistance
Oxidative Stress
Glucose Intolerance

Treatments

Drug: Vitamin D
Other: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT03356873
DIA-981-13/14-1

Details and patient eligibility

About

The investigators aim to determine the effect of the correction of vitamin D in vitamin D deficient patients (<15ng/ml) in oxidative stress and insulin resistance in patients with impaired glucose tolerance. Vitamin D deficiency has been associated with chronic low-grade inflammation, diabetes mellitus type 2, cardiovascular risk and increased prevalence of coronary heart disease, cerebrovascular disease and myocardial infarction.

Enrollment

31 patients

Sex

Female

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women, 18 to 70 years, glucose intolerance (post-2 hour 75-grams glucose load > or equal 140 mg/dl), 25-hydroxy vitamin D concentration < or equal 15 ng/ml

Exclusion criteria

  • Diabetes, systemic inflammatory disorders, treatment with statins, metformin or fibrates, renal insufficiency, intestinal malabsorption

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

31 participants in 2 patient groups, including a placebo group

Active
Experimental group
Description:
Vitamin D 5000 units capsules, 20 capsules per week during four weeks (total 400,000 units)
Treatment:
Drug: Vitamin D
Placebo
Placebo Comparator group
Description:
Identical placebo capsules, 20 capsules per week during four weeks
Treatment:
Other: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems